Improving the therapeutic potential of endostatin by fusing it with the BAX BH3 death domain-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Improving the therapeutic potential of endostatin by fusing it with the BAX BH3 death domain

Published:2014-08 Issue:8 Volume:5 Page:e1371-e1371
ISSN:2041-4889
Container-title:Cell Death & Disease
language:en
Short-container-title:Cell Death Dis

Author:

Chura-Chambi R M,Bellini M H,Jacysyn J F,Andrade L N,Medina L P,Prieto-da-Silva Á R B,Amarante-Mendes G P,Morganti L

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology

Link

http://www.nature.com/articles/cddis2014309.pdf

Reference43 articles.

1. Boehm T, Folkman J, Browder T, O’Reilly MS . Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 1997; 390: 404–407.

2. Dixelius J, Larsson H, Sasaki T, Holmqvist K, Lu L, Engstrom A et al. Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis. Blood 2000; 95: 3403–3411.

3. Sudhakar A, Sugimoto H, Yang C, Lively J, Zeisberg M, Kalluri R . Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins. Proc Natl Acad Sci USA 2003; 100: 4766–4771.

4. MacDonald NJ, Shivers WY, Narum DL, Plum SM, Wingard JN, Fuhrmann SR et al. Endostatin binds tropomyosin. A potential modulator of the antitumor activity of endostatin. J Biol Chem 2001; 276: 25190–25196.

5. Lee SJ, Jang JW, Kim YM, Lee HI, Jeon JY, Kwon YG et al. Endostatin binds to the catalytic domain of matrix metalloproteinase-2. FEBS Lett 2002; 519: 147–152.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural studies of the protein endostatin in fusion with BAX BH3 death domain, a hybrid that presents enhanced antitumoral activity;Biotechnology and Applied Biochemistry;2016-09-23

2. Glipizide suppresses prostate cancer progression in the TRAMP model by inhibiting angiogenesis;Scientific Reports;2016-06-13

3. Matricryptins Network with Matricellular Receptors at the Surface of Endothelial and Tumor Cells;FRONT PHARMACOL;2016

4. Matricryptins Network with Matricellular Receptors at the Surface of Endothelial and Tumor Cells;Frontiers in Pharmacology;2016-02-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3